Assessing the effectiveness of synthetic and biologic disease-modifying antirheumatic drugs in psoriatic arthritis - a systematic review.

about

Assessing the effectiveness of synthetic and biologic disease-modifying antirheumatic drugs in psoriatic arthritis - a systematic review.

Item

http://www.wikidata.org/entity/Q55109332

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Assessing the effectiveness of ...... thritis - a systematic review.

@en

Assessing the effectiveness of ...... thritis - a systematic review.

@nl

type

Item

label

Assessing the effectiveness of ...... thritis - a systematic review.

@en

Assessing the effectiveness of ...... thritis - a systematic review.

@nl

prefLabel

Assessing the effectiveness of ...... thritis - a systematic review.

@en

Assessing the effectiveness of ...... thritis - a systematic review.

@nl

P1476

Assessing the effectiveness of ...... thritis - a systematic review.

@en

P2093

David L Scott

http://www.w3.org/2001/XMLSchema#string

Gabrielle H Kingsley

http://www.w3.org/2001/XMLSchema#string

P2860

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Assessing the Risk of Bias of Individual Studies in Systematic Reviews of Health Care Interventions

Measuring inconsistency in meta-analyses

Meta-analysis in clinical trials

Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor.

Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phas

Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses.

Systematic review of treatments for psoriatic arthritis: an evidence based approach and basis for treatment guidelines.

Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease modifying antirheumatic drug therapy.

The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis

P304

71-81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/PTT.S52893

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29387584

http://www.w3.org/2001/XMLSchema#string

P932

5683113

http://www.w3.org/2001/XMLSchema#string